Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Reata Pharmaceuticals, Inc.
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-05-15
Sale		2023-05-17
4:51 pm		REATA PHARMACEUTICALS INCRETAWORTLEY MICHAEL D
Chief Legal Officer		1,311$83.59$109,58946,781
(Direct)		View
2023-05-15
Sale		2023-05-17
4:39 pm		REATA PHARMACEUTICALS INCRETASoni Manmeet Singh
COO, CFO and President		22,132$84.45$1,869,150116,172
(Direct)		View
2023-05-15
Sale		2023-05-17
4:34 pm		REATA PHARMACEUTICALS INCRETAMeyer Colin John
Chief Innovation Officer		6,233$84.56$527,06378,373
(Direct)		View
2023-05-15
Sale		2023-05-17
4:29 pm		REATA PHARMACEUTICALS INCRETAKhan Samina
SVP, Chief Medical Officer		640$83.15$53,21439,491
(Direct)		View
2023-05-15
Sale		2023-05-17
4:26 pm		REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer		1,086$85.37$92,71425,679
(Direct)		View
2023-05-15
Sale		2023-05-17
4:21 pm		REATA PHARMACEUTICALS INCRETABir Dawn Carter
Chief Commercial Officer		1,311$83.77$109,82930,885
(Direct)		View
2023-05-12
Sale		2023-05-16
4:17 pm		REATA PHARMACEUTICALS INCRETALoewen Andrea
SVP, Global Regulatory Affairs		7,166$86.01$616,35231,591
(Direct)		View
2023-03-13
Sale		2023-03-15
4:44 pm		REATA PHARMACEUTICALS INCRETABir Dawn Carter
Chief Commercial Officer		9,317$86.77$808,43632,196
(Direct)		View
2023-03-10
Sale		2023-03-13
5:23 pm		REATA PHARMACEUTICALS INCRETARuff Shamim
Director		5,740$83.73$480,6107,071
(Direct)		View
2023-03-07
Sale		2023-03-09
4:47 pm		REATA PHARMACEUTICALS INCRETALoewen Andrea
SVP, Global Regulatory Affairs		19,036$83.43$1,588,13773,757
(Direct)		View
2023-03-06
Sale		2023-03-08
5:17 pm		REATA PHARMACEUTICALS INCRETABir Dawn Carter
Chief Commercial Officer		96,996$87.67$8,503,621173,143
(Direct)		View
2023-03-07
Sale		2023-03-08
5:08 pm		REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer		165$84.58$13,95626,765
(Direct)		View
2023-03-07
Sale		2023-03-08
5:04 pm		REATA PHARMACEUTICALS INCRETAMeyer Colin John
Chief Innovation Officer		621$84.57$52,51884,606
(Direct)		View
2023-03-07
Sale		2023-03-08
5:01 pm		REATA PHARMACEUTICALS INCRETASoni Manmeet Singh
COO, CFO and President		622$84.69$52,68088,304
(Direct)		View
2023-03-07
Sale		2023-03-08
4:59 pm		REATA PHARMACEUTICALS INCRETAWORTLEY MICHAEL D
Chief Legal Officer		414$84.46$34,96648,092
(Direct)		View
2023-03-07
Sale		2023-03-08
4:56 pm		REATA PHARMACEUTICALS INCRETAKhan Samina
SVP, Chief Medical Officer		3,961$83.46$330,58540,131
(Direct)		View
2023-03-02
Sale		2023-03-06
5:04 pm		REATA PHARMACEUTICALS INCRETAMeyer Colin John
Chief Innovation Officer		93,922$86.72$8,145,224322,471
(Direct)		View
2023-03-03
Sale		2023-03-06
4:51 pm		REATA PHARMACEUTICALS INCRETAWORTLEY MICHAEL D
Chief Legal Officer		2,169$87.57$189,93948,506
(Direct)		View
2023-03-03
Sale		2023-03-06
4:48 pm		REATA PHARMACEUTICALS INCRETASoni Manmeet Singh
COO, CFO and President		3,587$87.97$315,54888,926
(Direct)		View
2023-03-02
Sale		2023-03-06
4:44 pm		REATA PHARMACEUTICALS INCRETALoewen Andrea
SVP, Global Regulatory Affairs		1,819$88.08$160,20942,793
(Direct)		View
2023-03-02
Sale		2023-03-06
4:40 pm		REATA PHARMACEUTICALS INCRETAKhan Samina
SVP, Chief Medical Officer		27,813$85.13$2,367,71669,092
(Direct)		View
2023-03-03
Sale		2023-03-06
4:31 pm		REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer		820$87.47$71,72526,930
(Direct)		View
2023-03-03
Sale		2023-03-06
4:28 pm		REATA PHARMACEUTICALS INCRETABir Dawn Carter
Chief Commercial Officer		2,166$88.25$191,14848,509
(Direct)		View
2023-03-02
Sale		2023-03-03
5:09 pm		REATA PHARMACEUTICALS INCRETAHuff James Warren
Chief Executive Officer		75,000$85.46$6,409,473881,754
(Indirect
Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-05-05
Option Award		2023-05-09
4:35 pm		2023-05-05
2029-08-28		REATA PHARMACEUTICALS INCRETASoni Manmeet Singh
COO, CFO and President		50,000$0188,304
(Direct)		View
2023-03-10
Exercise		2023-03-13
5:23 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETARuff Shamim
Director		5,541$34.767,071
(Direct)		View
2023-03-10
Exercise		2023-03-13
5:23 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETARuff Shamim
Director		199$27.327,071
(Direct)		View
2023-03-10
Exercise		2023-03-13
5:23 pm		N/A
2032-01-03		REATA PHARMACEUTICALS INCRETARuff Shamim
Director		5,740$07,071
(Direct)		View
2023-03-07
Exercise		2023-03-09
4:47 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETALoewen Andrea
SVP, Global Regulatory Affairs		15,000$27.3273,757
(Direct)		View
2023-03-07
Exercise		2023-03-09
4:47 pm		N/A
2032-01-03		REATA PHARMACEUTICALS INCRETALoewen Andrea
SVP, Global Regulatory Affairs		15,000$073,757
(Direct)		View
2023-03-06
Conversion		2023-03-08
5:17 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETABir Dawn Carter
Chief Commercial Officer		90,000$0173,143
(Direct)		View
2023-03-06
Exercise		2023-03-08
5:17 pm		N/A
2026-09-06		REATA PHARMACEUTICALS INCRETABir Dawn Carter
Chief Commercial Officer		90,000$0173,143
(Direct)		View
2023-03-06
Exercise		2023-03-08
5:17 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETABir Dawn Carter
Chief Commercial Officer		90,000$21.05173,143
(Direct)		View
2023-03-03
Gift		2023-03-07
4:37 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETAMcGaughy R Kent Jr
Director
10% Owner		33,217$02,926,776
(Indirect)		View
2023-03-02
Conversion		2023-03-06
5:04 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETAMeyer Colin John
Chief Innovation Officer		88,636$0322,471
(Direct)		View
2023-03-02
Exercise		2023-03-06
5:04 pm		N/A
2026-05-25		REATA PHARMACEUTICALS INCRETAMeyer Colin John
Chief Innovation Officer		88,636$0322,471
(Direct)		View
2023-03-02
Exercise		2023-03-06
5:04 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETAMeyer Colin John
Chief Innovation Officer		88,636$11322,471
(Direct)		View
2023-03-02
Exercise		2023-03-06
4:40 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETAKhan Samina
SVP, Chief Medical Officer		25,000$27.3269,092
(Direct)		View
2023-03-02
Exercise		2023-03-06
4:40 pm		N/A
2032-01-03		REATA PHARMACEUTICALS INCRETAKhan Samina
SVP, Chief Medical Officer		25,000$069,092
(Direct)		View
2023-03-01
Conversion		2023-03-03
5:09 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETAHuff James Warren
Chief Executive Officer		75,000$0881,754
(Direct)		View
2023-03-01
Option Award		2023-03-02
5:15 pm		N/A
2032-05-20		REATA PHARMACEUTICALS INCRETAAnand Bhaskar
SVP, Chief Accounting Officer		9,000$033,750
(Direct)		View
2023-02-28
Option Award		2023-03-01
4:18 pm		N/A
2032-01-03		REATA PHARMACEUTICALS INCRETAMeyer Colin John
Chief Innovation Officer		45,000$0120,513
(Direct)		View
2023-02-28
Option Award		2023-03-01
4:16 pm		N/A
2032-03-16		REATA PHARMACEUTICALS INCRETASoni Manmeet Singh
COO, CFO and President		75,000$075,000
(Direct)		View
2023-01-03
Option Award		2023-01-04
5:35 pm		N/A
2033-01-03		REATA PHARMACEUTICALS INCRETAHuff James Warren
Chief Executive Officer		237,975$01,743,517
(Direct)		View
2023-01-03
Option Award		2023-01-04
5:17 pm		N/A
2033-01-03		REATA PHARMACEUTICALS INCRETASoni Manmeet Singh
COO, CFO and President		118,988$0187,988
(Direct)		View
2023-01-03
Option Award		2023-01-04
5:12 pm		N/A
2033-01-03		REATA PHARMACEUTICALS INCRETAWORTLEY MICHAEL D
Chief Legal Officer		79,325$0114,325
(Direct)		View
2023-01-03
Option Award		2023-01-04
5:01 pm		N/A
2033-01-03		REATA PHARMACEUTICALS INCRETAMeyer Colin John
Chief Innovation Officer		118,988$0170,988
(Direct)		View
2023-01-03
Option Award		2023-01-04
4:50 pm		N/A
2033-01-03		REATA PHARMACEUTICALS INCRETALoewen Andrea
SVP, Global Regulatory Affairs		59,494$092,350
(Direct)		View
2023-01-03
Option Award		2023-01-04
4:48 pm		N/A
2033-01-03		REATA PHARMACEUTICALS INCRETAKhan Samina
SVP, Chief Medical Officer		59,494$094,643
(Direct)		View
2023-01-03
Option Award		2023-01-04
4:11 pm		N/A
2033-01-03		REATA PHARMACEUTICALS INCRETABir Dawn Carter
Chief Commercial Officer		79,325$0114,325
(Direct)		View
2023-01-03
Option Award		2023-01-04
4:07 pm		N/A
2033-01-03		REATA PHARMACEUTICALS INCRETAAnand Bhaskar
VP, Chief Accounting Officer		41,750$058,250
(Direct)		View
2022-07-11
Option Award		2022-07-12
4:26 pm		N/A
2032-07-11		REATA PHARMACEUTICALS INCRETARyder Steven
Director		11,530$021,730
(Direct)		View
2022-07-11
Option Award		2022-07-12
4:26 pm		N/A
2032-07-11		REATA PHARMACEUTICALS INCRETARyder Steven
Director		1,322$22.3621,730
(Direct)		View
2022-07-11
Option Award		2022-07-12
4:26 pm		N/A
N/A		REATA PHARMACEUTICALS INCRETARyder Steven
Director		8,878$32.3621,730
(Direct)		View
2022-06-08
Option Award		2022-06-10
6:33 pm		N/A
2032-06-08		REATA PHARMACEUTICALS INCRETAMcGaughy R Kent Jr
Director
10% Owner		11,240$016,027
(Direct)		View
2022-06-08
Option Award		2022-06-10
6:33 pm		N/A
2032-06-08		REATA PHARMACEUTICALS INCRETAMcGaughy R Kent Jr
Director
10% Owner		4,787$24.0216,027
(Direct)		View
Goto 0, 1, 2, 3, 4, Next